Analysis of neglected tropical disease drug and vaccine development pipelines to predict issuance of FDA priority review vouchers over the next decade

PLoS Negl Trop Dis. 2012;6(10):e1803. doi: 10.1371/journal.pntd.0001803. Epub 2012 Oct 25.
No abstract available

Publication types

  • Review

MeSH terms

  • Communicable Diseases / drug therapy*
  • Communicable Diseases / epidemiology
  • Drug Approval
  • Drug Discovery / trends*
  • Humans
  • Neglected Diseases / drug therapy*
  • Neglected Diseases / epidemiology
  • Neglected Diseases / prevention & control*
  • Tropical Medicine / trends
  • United States
  • United States Food and Drug Administration
  • Vaccines / immunology*

Substances

  • Vaccines

Grants and funding

The authors received no specific funding for this article.